687 Proteomic profiling in blood identifies novel pretreatment and mechanistic markers related to inflammatory adverse events in relapsed/refractory large B-cell lymphoma after axicabtagene ciloleucel

Authors :: Kelly Speth
Gayatri Tiwari
Sabina Adhikary
Qinghua Song
Justin Chou
Frederick Locke
Caron Jacobson
David Miklos
Olalekan Oluwole
Marie José Kersten
Max Topp
Jenny Kim
Adrian Bot
Source :: Regular and Young Investigator Award Abstracts.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools